UnknownNot Applicable

RCA for CRRT in Liver Failure and High Risk Bleeding Patients

China90 participantsStarted 2018-09-06

Plain-language summary

The purpose of this single center, randomized, control, open-labeled study is to evaluate the effect and safety of RCA versus no anticoagulation for CRRT in patients with liver failure and high risk bleeding.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Liver failure (acute liver failure and chronic liver failure) * High bleeding risk * Scheduled CRRT treatment * Informed consent Exclusion Criteria: * Use of other anticoagulants * Uncorrectable hypoxemia (PaO2 \< 60 mmHg) or systemic hypoperfusion shock * Pregnancy or lactation * Fistula, CRRT treatment time \< 12 hours

What they're measuring

Filter failure

Timeframe: 72 hours

Trial details

NCT IDNCT03791190

SponsorAir Force Military Medical University, China

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-08-30

Contact for this trial

Shiren Sun, Doctor

+8602984775193 sunshiren@medmail.com.cn

View on ClinicalTrials.gov More Liver Failure trials